Pfizer fights for more protection for their new combo drug Duavee – But why?

by JANE ALLIN In July of 2013 the pharmaceutical company Bayer petitioned the FDA’s policy for “New Chemical Entity” (NCE) exclusivity in regard to fixed-dosed combination drugs (FCD), consisting of at least one new drug product, to be eligible for five years. Under the guidelines at the time fixed-dose drug combinations containing a drug entity… Continue reading Pfizer fights for more protection for their new combo drug Duavee – But why?